LA JOLLA, Calif., Sept. 28 /PRNewswire-FirstCall/ -- Liberty Mint, Ltd. (BULLETIN BOARD: LBML) (“the Company”) announced today that it has signed a definitive merger agreement with Akesis Pharmaceuticals Inc. of La Jolla, Ca. Akesis Pharmaceuticals develops novel patented therapies for the treatment of diabetes and other metabolic disorders. Additional information regarding the proposed transaction may be found on the Company’s filing on Form 8K for September 28, 2004.
Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. The realization of any or all of these expectations is subject to a number of risks and uncertainties and it is possible that the assumptions made by management may not materialize.
For further information please contact Nathan W. Drage, +1-801-273-9300, for Liberty Mint, Ltd.
Liberty Mint, Ltd.
CONTACT: Nathan W. Drage, +1-801-273-9300, for Liberty Mint, Ltd.
